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Abstract
Goals: Our goal was to establish the level of life quality in patients with chronic heart failure (CHF), and to find out whether there was 
a connection between their gender, socio-demographic status, BMI, number of comorbidities, NYHA class, treatment regime, time of 
treatment, age, and quality of life.
Methods: This research was conducted in 2018 at cardiology outpatient wards in patients with CHF using the standardized Minnesota 
Living with Heart Failure Questionnaire (MLHFQ). In order to perform complex monitoring of the relations among the variables within 
the study we conducted regression analysis, however, in exploratory regime as a descriptive technique, and so regardless of the value of 
statistical significance, and without an attempt to generalize. The model was realized using the ENTER method. Our goal was to include 
all of the above variables in it. We then estimated the relative power of influence using a standardized beta coefficient.
Results: Based on the values of this coefficient we can say that an increasing NYHA class, and being a male disabled retiree has the most 
significant influence on life quality. Adherence to the treatment regime does not have a significant impact on life quality; in fact, strict 
adherence to it may even result in its worsening.
Conclusions: For patients with a different NYHA class, treatment goals may differ. It is important for them to be aware of the fact that even 
if adherence to the treatment regime interferes with their quality of life, adherence to it is necessary in order to slow down the progress 
of this serious disease.
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Introduction
Chronic heart failure (CHF) is a syndrome of heart disease, in 
which despite adequate filling of the ventricles, cardiac output 
per minute decreases and the heart is not able to cover the 
metabolic needs of the tissues. Manifestations of CHF with-
out a drop in cardiac output might occur during inadequate in-
crease of filling pressure of the ventricles. In order to diagnose 
CHF, there must be symptoms, evidence of heart failure, and 
objectively proven impairment of heart functioning (Špinar et 
al., 2012).
Chronic heart failure is a complex clinical syndrome that 
affects patients with various cardiovascular diseases. It has se-
vere consequences, significantly decreases lifespan, and has a 
negative impact on life quality (Málek and Schejbalová, 2011). 
It is the final stage of almost all cardiovascular diseases, and is 
a significant cause of morbidity and mortality (Riedel, 2009, 
p. 407). The clinical picture shows mainly dyspnoea, cough, fa-
tigue, ineffectiveness, peripheral edema, stenocardia (Špinar 
et al., 2012); and in an advanced state also depressions and de-
liriums – especially in older patients, development of cardiac 
cachexia with muscle loss, incontinence, self-care deficit, etc. 
(Halmo et al., 2015).
To specify the severity of CHF, NYHA classification (cri-
teria processed by the New York Heart Association), ejection 
fraction or sodium level are generally used (McMurray et al., 
2012; Widimský et al., 2013). Treatment of CHF must be com-
plex, which includes a whole range of non-pharmaceutical 
measures, pharmacotherapy, and in indicated cases various 
kinds of surgery (Hradec and Býma, 2015; Špinar et al., 2012).
The prevalence of patients with CHF in the Czech Repub-
lic (CR) is estimated to be between 100,000 and 200,000 with 
approximately 40,000 new cases appearing annually. Thanks 
to increasingly effective treatment, mortality has been signif-
icantly limited to mostly acute cardiovascular complications. 
Despite this, the surviving patients have a more or less affect-
ed myocardium, and CHF gradually develops in them. Approx-
imately 50% of them die within 5 years of being diagnosed. 
Patients with CHF are very often polymorbid, usually older, of 
female gender, obese, with hypertension and diabetes mellitus 
(Hradec and Býma, 2015; Vojáček et al., 2017).
CHF decreases lifespan, affects all domains of life quality, 
and thus has an impact on physical health, health condition, 
the patients’ environment, and social relations. Despite this, 
patients often underestimate the severity of their condition 
and adherence to the recommended treatment regime (Luo et 
al., 2019; Obiegło et al., 2017).
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Adverse health condition might lead to repeated hospital-
izations, disability, and financial inadequacy. Physical symp-
toms, adverse effects of treatment, disease, but also financial 
inadequacy might decrease life quality by up to 40% (Hopp 
et al., 2010; Luo et al., 2019; Volz et al., 2011). Decreased life 
quality in patients with CHF is connected to depressions (Bun-
yamin et al., 2013; Vévodová et al., 2017). Effective education 
of the patient and his/her family members may improve col-
laboration and increase adherence to treatment. In a similar 
fashion, effective nursing management and self-management 
of the patients with CHF may decrease the number of hospi-
talizations, improve the condition and life quality in patients 
with CHF, and decrease costs of their treatment (Abbasi et al., 
2018; Ghanbari-Firoozabadi et al., 2014; Hradec and Býma, 
2015; Mainardi et al. 2006; Travis et al., 2012).
Our task was to establish the level of life quality of our re-
spondents using the MLHFQ, and find out whether there is 
a connection between their gender, socio-demographic status, 
BMI, the number of comorbidities, degree of NYHA, treatment 
regime, length of disease/treatment, age, and life quality. In 
order to do this we set three goals.
Goals
1. To find out whether the patients adhere to basic treatment 
measures in connection to CHF
2. To establish life quality in patients with CHF in the past 
month using the MLHFQ
3. To find out if there is a connection between their gender, 
socio-demographic status, BMI, the number of comorbid-
ities, NYHA degree, treatment regime, time of treatment, 
age, and quality of life (MLHFQ).
 
Materials and methods
We applied an innovative quantitative research technique us-
ing a questionnaire composed of three parts. Part 1 focused 
on socio-demographic data (gender, age, height, weight, du-
ration of treatment, socioeconomic position, and dyspnoea 
assessment according to NYHA) – a total of 7 items; Part 2 – 
standardized Minnesota Living with Heart Failure Questionnaire 
(MLHFQ) – a total of 21 items; Part 3 – focused on adherence 
to treatment measures – a total of 10 items; time to fill out the 
questionnaire – 20 minutes.
The standardized MLHFQ is focused on individual symp-
toms of heart failure that have affected the patient’s (respond-
ent’s) life quality in the past month. Each item is assessed 
using a six point Likert scale ranging from 0 to 5 (zero = no 
limitation, 5 = maximum limitation). The MLHFQ was written 
in 1984 by Thomas S. Rector and Jay N. Cohn from the Car-
diovascular Center with the University of Minnesota. A one-
time license to the MLHFQ was provided by the University of 
Minnesota (Office for Technology Commercialization) for the 
purpose of this study (Rector, 2017, p. 4).
The MLHFQ score was summarized based on assessment 
criteria from 21 questions. The number of points the respond-
ents could get was from 0 to 105; the higher the score, the 
greater the limitation of the patient with CHF. Physical score 
is assessed based on items 2, 3, 4, 5, 6, 7, 12, 13 as a sum of 
points from individual items. The value of physical score rang-
es between 0 and 40 (0 means no limitation, 40 maximum lim-
itation). The emotional aspect is presented by items 17, 18, 19, 
20, 21. The emotional score ranges from 0 to 25 (0 means no 
limitation, 25 maximum limitation) (Rector, 2017, p. 6).
The survey took place between April 2018 and September 
2018 in cardiology outpatient wards in patients with CHF.
Characteristics of the survey pool
The questionnaire could be filled out by: patients treated in 
heart failure outpatient wards, patients treated with CHF for 
at least one year, adult patients with NYHA I–IV (New York 
Heart Association – classification of dyspnoea in patients with 
CHF), BMI was calculated based on actual measurements of 
height and weight at the outpatient ward, and the respondents 
were willing to fill out this anonymous questionnaire.
Organization and data processing
Once the permission of the respective medical facility was 
granted, the patients that met the criteria and competent 
persons (nurse practitioners) from the selected outpatient 
wards were asked for cooperation. At the outpatient wards the 
patients were informed of the goals of the study and how to 
fill out the questionnaire. Then their height and weight were 
taken, and their current status within the NYHA classification 
verified. The BMI (body mass index) was calculated based on 
the formula [weight (kg)/height (m)]. The NYHA criteria pro-
cessed by the New York Heart Association were used to assess 
heart failure: I. No limitation of physical activity. Normal ef-
fort does not result in feelings of exhaustion, dyspnoea, palpi-
tation or angina pectoris; II. Slight limitation of physical activ-
ity. Normal effort leads to exhaustion, dyspnoea, palpitations 
or angina pectoris; III. Serious limitation of physical activity. 
Even little effort leads to exhaustion, dyspnoea, palpitations 
or angina pectoris; IV. Problems with any kind of physical ac-
tivity leading to the patient’s disability. Dyspnoea, palpitations 
or angina pectoris appear even without performing any phys-
ical activity (McMurray et al., 2012; The Criteria Committee 
of the New York Heart Association, 1994, pp. 253–256). The 
patients filled out the questionnaires in waiting rooms with 
plenty of time to do so.
It is an exploratory study using an intentional pool of re-
spondents who had to meet the given criteria in order to be 
allowed to partake in the study. Procedures of inference statis-
tics were intentionally not applied within the analysis, instead 
measures of material significance were used as these are cru-
cial for applying the results in practice, and are independent of 
the representativeness and size of the research pool (Soukup, 
2013).
 
results
282 respondents partook in the survey, of which 174 were 
men (62%) and 108 women (38%), aged 22 to 80 (average age 
of 53, SD = 15.2). More detailed characteristics of the respond-
ents and their division based on gender are shown in Table 1.
Only 26 respondents (10%) had a BMI within normal 
range, 117 (i.e. 45%) were overweight, and 115 (i.e. 45%) were 
obese.
The NYHA degree (New York Heart Association – classifi-
cation of dyspnoea) was verified for the respondents based on 
their current condition at the outpatient ward – Table 2.
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table 1. Characteristics of the pool
Male Female Total
 Min Max SD   Min Max SD   Min Max SD
Age 56.5 22.0 80.0 15.9 47.6 24.0 76.0 12.1 53.1 22.0 80.0 15.2
Weight 92.5 65.0 121.0 13.1 80.0 54.0 103.0 15.2 87.8 54.0 121.0 15.2
Height 176.0 160.0 191.0 6.8 165.0 153.0 180.0 8.3 171.8 153.0 191.0 9.2
BMI 29.88 23.88 40.56 4.09 29.27 22.60 38.21 4.73 29.65 22.60 40.56 4.35
Total no. of 
comorbidities (0–10)
3.7 1.0 10.0 1.9 3.6 0.0 9.0 1.8 3.7 0.0 10.0 1.9
Treatment duration 5.9 1.0 21.0 4.4 4.1 1.0 11.0 2.8 5.2 1.0 21.0 3.9
table 2. Assessment of dyspnoea in the respondents 
according to nYHA
Gender
Male Female Total
N % N % N %
NYHA
1
2
3
4
26
71
58
19
14.9
40.8
33.3
10.9
33
46
22
  7
30.6
42.6
20.4
  6.5
  59
117
  80
  26
20.9
41.5
28.4
  9.2
Respondents’ socioeconomic position
Regarding our respondents’ socioeconomic position – 54 (i.e. 
19.1%) were employed, 23 (i.e. 8.2%) unemployed, and 80 (i.e. 
28.4%) were disabled (without specifying degrees of disabil-
ity); 96 (34.0%) retired, 19 (6.7%) self-employed, and 10 re-
spondents (i.e. 3.5%) stated other.
Twenty respondents (7.1%) stated disability of the first de-
gree, 37 (13.1%) disability of the second degree, and 23 (8.2%) 
disability of the third degree. Most of the respondents with 
disability of the first and second degree were women (46 wom-
en, 11 men); while there were significantly more men with dis-
ability of the third degree (19 men, 4 women).
Results to Goal 1: To discover whether the patients adhered 
to basic treatment measures for CHF.
For each item (No. 7–16) the respondents could get 0–2 
points. The more points, the better the patient adheres to 
the treatment regime. A sum index was subsequently created 
from the items that could reach up 0–20 points. The results are 
shown in Table 3.
Score of adherence to the treatment regime by the 
respondents
The maximum number of points was 20, with respondents 
reaching at least 15 points (75%) considered as those adhering 
to the treatment regime. 31 respondents reached 15 or more 
points (11 %).
Results of Goal 2: To find out what the life quality of the 
respondents with CHF had been like in the past one month – 
according to the MLHFQ.
Individual MLHFQ items are shown in Table 4.
The total mean score according to the MLHFQ was 47.96 ± 
19.86 (40.88 in women, 52.35 in men). The total average emo-
tional score according to the MLHFQ was 10.50 ± 5.39 (8.95 
in women, 11.45 in men). The total mean physical score based 
on the MFHFQ was 19.19 ± 7.43 (16.44 in women a 20.90 in 
men).
table 3. Adherence to treatment measures in the respondents
Min Max Mean SD Median Modus
7. Regular weight checks 0 2 0.76 0.71 1 1
8. Regular use of only physician-prescribed medicines 1 2 1.75 0.43 2 2
9. Increased doses of diuretics after sudden increase of 
weight > 2 kg/3 days (or contacting attending doctor)
0 2 1.02 0.98 1 2
10. Decreasing salt intake < 4–5g NaCl/day 0 2 1.04 0.76 1 1
11. Elimination of foods with great salt content 0 2 0.56 0.72 0 0
12. Adherence to daily intake of liquids according to 
physician's recommendation
0 2 1.59 0.75 2 2
13. Modest consumption of alcohol (if not counter-
indicated)
0 2 1.54 0.75 2 2
14. Strict smoking ban 0 2 1.00 0.79 1 1
15. Adequate physical exercises in respect to the degree 
of NYHA and physician’s recommendation
0 2 1.01 0.92 1 2
16. Reduction of weight in overweight and obese 
patients
0 2 0.49 0.86 0 0
Total number of points for items 7–16 (0–20 points) 1 18 10.76 3.85 11 10
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table 4. Individual items of the MLHFQ (the higher the mean, the greater the suffering)
Min Max Mean SD Median Modus
17. Swollen ankles 0 5 2.28 1.07 2 2
18. The need to sit or lie down to rest during the day 1 4 2.57 0.95 2 2
19. Difficulties while strolling or walking upstairs 
(dyspnoea, fatigue)
1 5 2.84 1.17 3 2
20. Difficulties while working around the house or 
garden
1 5 2.66 1.02 3 2
21. Limitations going for walks outside 0 5 1.94 1.34 2 3
22. Disrupted sleep at night 0 5 1.82 1.38 2 2
23. Limitations in performing joint activities with 
friends or family
0 5 2.03 1.27 2 3
24. Limitations in the possibility to earn money 0 5 2.31 1.92 2 0
25. Limitations in performing hobbies, sports and 
recreational activities
0 5 2.52 1.47 2 3
26. Limitations in sexual life 0 5 2.83 1.77 3 4
27. Limitations in eating (eating less than was usual) 0 5 2.35 1.03 2 3
28. More pronounced breathing 1 5 2.83 1.09 3 2
29. Fatigue, exhaustion or lack of energy 0 5 2.51 0.97 3 2
30. Recent hospitalization 0 5 1.46 1.56 1 0
31. Impression of financial difficulties connected to 
medical care being provided
0 5 2.33 1.19 2 2
32. Adverse effects of medicines 0 5 2.18 1.42 2 2
33. Feelings of being a burden to family or friends 0 5 2.12 1.30 2 3
34. Feelings of loss of self-sufficiency 0 5 2.12 1.28 2 2
35. Growing fears of the future 0 5 2.46 1.41 2 3
36. Growing difficulties with memory and concentration 0 5 1.80 1.47 2 0
37. Feelings of anxiety and depression 0 5 1.99 1.13 2 3
Results of Goal 3: To find the relationship between gender, 
socio-demographic status, BMI, the number of comorbidities, 
NYHA degree, treatment regime, time of treatment, age, and 
quality of life.
The last goal is focused on a complex monitoring of the re-
lationships between the variables monitored within the study. 
Regression analysis was conducted to reach this goal, howev-
er, only in exploratory regime as a descriptive technique, and 
so without regard to the values of statistical significance and 
without an attempt to generalize them (Mareš et al., 2015, p. 
341); on the contrary with emphasis on measures of material 
significance (Soukup, 2013). The model was carried out using 
the method ENTER, our goal being to include in it all the be-
low mentioned variables.
Life quality was included in this model as a dependent vari-
able (in the sense of the total number of points in the MLHFQ, 
when an increasing number of points means an increasing lim-
itation to life quality caused by heart failure).
As independent variables we included: the respondents’ 
gender, socioeconomic position, BMI (found to be between 
22.6 and 40.6 in the pool), number of comorbidities (0–10 
total), degree of NYHA (1–4), total level of adherence to the 
treatment regime (sum index based on items 7–16 theoretical-
ly reaching 0–20 points), treatment duration in years (found 
to be between 1–21 years in the pool), age in years (found to 
be 22–80 years in the pool).
Result
Due to multicollinearity (tolerance value ≤0.2; VIF value ≥5) 
we merged 2 variables in the model relating to socioeconomic 
position: disability (without specifying the levels) and retirees. 
We did not include respondents who stated their socioeco-
nomic as ‘other’ as it would add the element of indefiniteness, 
which was not desired, and also because it was the least nu-
merous group of respondents. There were ten such respond-
ents. So we worked with 272 respondents, thus complying 
with basic recommendations as to the size of the pool (Mareš 
et al., 2015, p. 357).
The resulting model of regression analysis was (F = 75.991; 
df = 13; sig. < 0.0005; R2 = 0,79; adjusted R2 = 0.78). While 
using our spectrum of independent variables we are able to ex-
plain 78% of the dispersion of dependent variable, which is a 
very good result.
The model below will help us to estimate the influence 
of every independent variable on dependent variable (while 
controlling the function of the other independent variables), 
using nonstandardized regression coefficients B. We then esti-
mate relative strength of influence (in comparison to the other 
variables) using standardized coefficient beta.
The other values in Table 5 (Std. Error, t, Sig.) are pointless 
for our purposes because we do not generalize, but work only 
at the descriptive level.
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table 5. regression analysis model
Nonstandardized coefficients Standardized 
coefficients T Sig.
Collinearity statistics
B Std. Error Beta Tolerance VIF
(Constant) 12.776 7.004 1.824 0.069
Gender = male 6.340 1.437 0.155 4.411 0.000 0.652 1.535
Work position: Unemployed. 6.764 2.827 0.094 2.393 0.017 0.518 1.932
Work position: Self-
employed
6.149 2.913 0.078 2.111 0.036 0.581 1.723
Disabled or retired 8.050 1.995 0.193 4.034 0.000 0.352 2.840
BMI –0.042 0.167 –0.009 –0.252 0.801 0.593 1.685
Total No. of comorbidities 
(0–10 points)
–0.038 0.426 –0.004 –0.089 0.929 0.506 1.978
NYHA = 2 17.714 1.737 0.435 10.199 0.000 0.442 2.263
NYHA = 3 33.994 2.216 0.776 15.338 0.000 0.314 3.186
NYHA = 4 47.835 3.197 0.704 14.961 0.000 0.362 2.761
Adherence to treatment 
regime (0–20 points)
0.619 0.205 0.121 3.015 0.003 0.499 2.006
Treatment duration in years 0.121 0.210 0.024 0.575 0.565 0.462 2.165
Age –0.043 0.067 –0.032 –0.649 0.517 0.339 2.952
Depressions 1.483 1.663 0.033 0.892 0.373 0.594 1.682
Interpretation of coefficients B:
• Men achieved 6.3 points more in the MLHFQ than women, 
while controlling the other independent variables.
• Unemployed respondents achieved 6.7 points more in the 
MLHFQ; self-employed 6.1 points more; disabled or retired 
respondents 8.0 points more than employed respondents, 
while controlling the other independent variables.
• The degree of NYHA is very important. Respondents with 
NYHA class 2 achieved 17.7 points more; those with NYHA 
class 3 achieved 33.9 points more, and those with NYHA 
class 4 achieved 47.8 points more compared to those with 
NYHA class 1.
• If the respondents stated that they suffered from depres-
sions, they had on average 1.8 points more than the other 
respondents. This influence was very weak.
• The BMI, the number of comorbidities, adherence to treat-
ment regime and age had a negligible or very weak influ-
ence.
Interpretation of standardized coefficients beta:
Based on the values of this coefficient we can say that accor-
ding to the MLHFQ, an increasing NYHA class has the most 
significant influence on the patients’ life quality, followed by 
being disabled or retired, and being a man. Only then do the 
other categories specified in the model play a role.
 
Discussion
The survey took place in specialized outpatient wards focused 
on heart failure (HF). The sample was made up of 282 respond-
ents, of which 174 (62%) were men and 108 (38%) were wom-
en. According to Hradec and Býma (2015) and also the recom-
mended procedure of the Czech Cardiology Society there are 
100,000–200,000 patients with CHF in the Czech Republic, 
and roughly the same number of patients with asymptomat-
ic systolic dysfunction of the left ventricle, most of whom 
eventually end up in the stage of manifesting HF. Incidence of 
HF exponentially rises with every decade. The average age of 
patients with CHF is between 74 and 76 (Hradec and Býma, 
2015; Špinar et al., 2012). According to the Framingham 
study, prevalence of HF in the people under 60 years of age 
is 0.8%, in people aged 60–69 years 2.3%, and in people over 
70 years of age 9.1% (Greenberg et al., 2010). The average age 
of the respondents in our study was 53 years (SD = 15.2); the 
women were on average 48 years old, the men 56. Thus our 
respondents were relatively young for patients with CHF. Av-
erage treatment duration was 4.1 years in the women and 5.9 
years in the men.
Based on the recommendation of the Czech Cardiology So-
ciety and the Society of General Medicine, ČLS JEP patients 
with CHF must be instructed regarding the necessity to mon-
itor symptoms of the disease and trimming body weight, and 
adherence to regime measures (Hradec and Býma, 2015). In 
our study, only 31 respondents (11%) achieved 15 or more 
points, most of them women – see Table 3. 90% of the patients 
were found to be overweight or obese, the BMI was between 
22.6 and 40.6, with the average of 29.6 (SD = 4.3). Average 
BMI in women was 29.3, in men 29.9 (overweight at the top 
limit). In spite of that the respondents failed to reduce weight 
within the treatment measures.
It is not easy to define life quality, and there is still no 
agreement on a definition. Besides the feeling of physical 
health it also includes mental condition, social position, reli-
gious and economic aspects. Life quality reflects the level of 
personal wellbeing, the ability to take care of oneself, one’s 
mobility and the ability to influence his/her own life (Slováček 
et al., 2004). However, experts agree that life quality is viewed 
as a multidimensional magnitude. The goal of HF treatment is 
to increase life quality, i.e. to decrease or completely remove its 
symptoms, to increase load tolerance, decrease mortality, and 
extend the patients’ lifespan (Lewis et al., 2001). However, for 
each patient the order and importance of these goals may be 
different. For patients that are a little symptomatic, decreasing 
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mortality and slowing down regression of the disease is a pri-
ority. For severely symptomatic patients, however, it is more 
important to be relieved from their health problems, and their 
life quality improved. CHF is not manifested only with physi-
cal symptoms. This disease also has a significant impact on the 
mental, social and economic areas. Patients with CHF live in 
a state of neverending limitations, without visible reward be-
cause CHF cannot be cured. Despite this, it is possible to slow 
its progressions through adherence to the treatment regime 
(Špinar et al., 2012).
Advanced heart failure means that patients, despite under-
going adequate therapy, have reached NYHA class III, or even 
NYHA class IV (Lazárová et al., 2012). In our study we had 
33.3% men and 20.4% women in NYHA class III, and 10.9% 
men and 6.5% women in NYHA class IV. Caring for patients 
with CHF is demanding due to a number of comorbidities con-
nected to this disease, which often require multidisciplinary 
collaboration (anemia, renal insufficiency, lung function or 
liver function impairment, hypothyreosis, depressions, etc.) 
(Lazárová et al., 2012). In our study we had 0–10 comorbidities 
with an average number of 3.6 in women and 3.7 in men. The 
most common were dyslipidemy (203 cases), diabetes mellitus 
(155 cases), liver disease (134 cases), anemia (77 cases), lung 
disease (60 cases), and depressions (74 cases), while the num-
ber of comorbidities had a negligible influence on life quality 
measured by the MLHFQ. If it increases by 1, the number of 
points in the questionnaire increases by 0.1.
The authors of this explorative study, Boman et al. (2017), 
reached the conclusion that it was anemia, not a lack of iron, 
that is connected to clinical symptoms and life quality in pa-
tients with severe heart failure and palliative home care.
In the past two years there has been a lot of evidence sup-
porting the importance of psychological variables for the prog-
nosis and life quality in patients with CHF. Multiple studies 
have proven that it is namely depression that has a negative in-
fluence on mortality (Volz et al., 2011). According to Vévodová 
et al. (2017), impaired life quality in patients with CHF has 
to do with depression, which is diagnosed in up to 36.5% of 
them. We cannot fully compare our results to those because 
they used a different measuring tool to measure life quality 
(the WHOQOL-BREF questionnaire), and worked with a sig-
nificantly smaller survey sample (110 respondents at cardiolo-
gy wards of three hospitals in the Czech Republic), from which 
it is impossible to generalize – even though confirmation re-
gime with hypotheses and statistical tests was applied in the 
study. However, our study also suggests that depressions are 
connected to life quality, but the connection is very weak. The 
study by Fotos et al. (2013) concludes that the mean life qual-
ity corresponds to 62.7 points. The mean life quality of our 
respondents corresponded to 44.6 points (Fotos et al., 2013). 
The closest to our results was Ms. Šenkyříková’s MLHFQ result 
(2014, p. 55), concluding that mean life quality corresponded 
to 44.9 points. A study by Buleu et al. (2019), showed a strong 
correlation between a lack of vitamin D in patients with CHF 
and the severity of heart failure, decrease in life quality, anxi-
ety and depression. However, it is necessary to continue with 
the research.
Based on our survey, we can conclude that a higher NYHA 
class has a significant negative influence on life quality. The in-
fluence of the BMI turned out to be negligible in our analysis.
The influence of adherence to medical procedures is very 
weak and negligible according to our study. On top of that it 
is slightly negative. The biggest problem is to keep motivating 
the patient to adhere to the treatment regime in the long run – 
even when it does not have a visible effect. This gives rise to an 
inconsistency between what the patient wants to do and what 
he has to do.
The study by Heo et al. (2015) focused on the knowledge of 
factors that can be influenced, adherence to dietary measures, 
and social support connected to life quality. This study proved 
that interventions focused on deepening the knowledge of fac-
tors that can be influenced may lead to improving control over 
heart failure, and thus increasing life quality (Heo et al., 2015). 
Our survey, just like the survey by Haluzíková and Hrubá 
(2015), did not turn out so positive (in the monitored areas 
of adherence to the treatment regime – regular application of 
prescribed medicines and adherence to dietary measures, and 
reducing the risk factor of smoking). The authors concluded 
that the patients relied more on medicines and assistance pro-
vided by physicians and nursing staff than making their own 
effort to change their lifestyle and adhere to regime measures.
By adhering to the treatment regime the patient loses part 
of his/her own autonomy. He/she must adhere to a number 
of strict limitations and bans (salt, alcohol, smoking, etc.  – 
see Table 3), and needs a balanced regime with plenty of rest, 
which concerns all kinds of activities – physical, mental, sex-
ual and other. The scale of limiting the patients’ activities 
depends on the scale of ventricular dysfunction and severity 
of the symptoms. With regard to one’s individual situation it 
is necessary to consider disability pension for many patients 
with NYHA class III–IV (Špinar et al., 2012). In our study, 
there were 23 (8.2%) unemployed people, a total of 80 (28.4%) 
disabled respondents (regardless of disability level), 96 retir-
ees (34.0%), and a total of 19 (6.7%) self-employed respond-
ents. Self-employed respondents scored 6.1 points more in 
the MLHFQ; unemployed 7.0 points more; disabled or retired 
respondents 8 points more compared to employed respond-
ents, while controlling other independent variables. Both our 
and foreign findings confirm that losing a job or disability may 
lead not only to worse life quality and a worse living standard, 
but also to a whole scale of other negative personality changes 
(decreased self-confidence, self-esteem, feelings of uselessness 
and hopelessness). Unemployment is considered as a key soci-
oeconomic determinant of health (Buchtová et al., 2002; Kli- 
ková and Kotlán, 2003).
Adherence to the treatment regime is not just about cor-
rect application of pharmacotherapy and adherence to the re-
gime measures, but also about active continual work with the 
patient’s environment and his/her own personal motivation. 
Thus far we do not work with support from the side of per-
sons with the same disease and their personal experience in 
this country.
 
Conclusions
The current CHF therapy is focused not only on influencing 
the symptoms, it also tries to influence the progression of 
heart failure and decrease mortality. Despite that, treatment 
goals might be different for a physician and a patient with any 
NYHA class. The survey showed that it is an increasing NYHA 
class that has the greatest influence on life quality in accord-
ance to MLHFQ, followed by being disabled or retired, and be-
ing of male gender. Adherence to the treatment regime does 
not have a significant influence on life quality. On the contra-
ry, extreme adherence to it might even lead to its worsening. 
Despite this, it is important for the patient to realize that ad-
herence to treatment measures is necessary in order to slow 
down the progression of this serious disease.
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Limitations of the study
A limitation of the study was its regional reach, thus the results 
cannot be generalized. Another limitation might be a lower av-
erage age of our respondents in comparison to presumed inci-
dence in the population, and the fact that there were a lot more 
men in the pool – 174 men (62%) and 108 women (38%).
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Kvalita života u pacientů s chronickým srdečním selháním
souhrn
Cíle: Naším úkolem bylo zjistit u pacientů s chronickým srdečním selháním (CHSS) míru kvality života a zda existuje vztah mezi 
pohlavím, sociodemografickým postavením, BMI, počtem komorbidit, stupněm NYHA (kritéria vypracovaná New York Heart 
Association), léčebným režimem, dobou léčení, věkem a kvalitou života.
Metodika: Výzkum byl realizován v roce 2018 na kardiologických ambulancích u pacientů s CHSS. K výzkumu byl použit stan-
dardizovaný „Minnesota Living with Heart Failure Questionnaire“ (MLHFQ). Za účelem komplexního sledování vztahů mezi 
proměnnými sledovanými v rámci studie byla realizována regresní analýza, avšak v exploračním režimu jako popisná technika, 
tedy bez ohledu na hodnoty statistické signifikance a bez nároku na zobecňování. Model byl realizován metodou ENTER a naším 
záměrem bylo zahrnout do něj všechny výše uvedené proměnné. Relativní sílu vlivu pak odhadujeme pomocí standardizovaného 
koeficientu beta.
Výsledky: Na základě hodnot tohoto koeficientu lze říci, že nejzásadnější vliv na kvalitu života podle MLHFQ má rostoucí stupeň 
NYHA, dále příslušnost k invalidům či důchodcům a příslušnost k mužům. Dodržování léčebného režimu nemá zásadní vliv na 
kvalitu života, dokonce při jeho větším dodržování dojde k jejímu zhoršení.
Závěr: Pro pacienta s různým stupněm NYHA mohou být léčebné cíle rozdílné. Důležité je, aby si byl vědom, že i když dodržování 
léčebného režimu zasahuje do jeho kvality života, je toto dodržování nezbytné ke zpomalení progrese tohoto závažného onemoc-
nění.
Klíčová slova: chronické srdeční selhání; kvalita života; MLHFQ; pacient; režimové opatření
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